Adverse reaction severity by Naranjo score interpretation.

NIAID Data Ecosystem2026-03-12 收录

不良药物反应

药物安全监测

数据链接：

https://figshare.com/articles/dataset/Adverse_reaction_severity_by_Naranjo_score_interpretation_/13569871 数据链接链接失效反馈

官方服务：

资源简介：

Adverse reaction severity by Naranjo score interpretation.

创建时间：

2021-01-13

药品不良反应数据库

不良药物反应

用药监测

为公开报道的临床用药出现的药物不良反应。内容包括：患者信息：性别、年龄等；药品信息：药品名称、成分、剂型、规格、用法用量、治疗类别、适应症、生产厂家等；用药情况：用药原因、给药途径等；药品不良反应情况：不良反应发生时间、症状、不良反应后果等；药品不良反应治疗情况：采取措施、治疗效果等。适用于药物研发、科研教育、医疗卫生和政府管理等方面。

中国科技资源共享网2026-07-12 更新400

Sensitivity analyses for the 1-month prevalence of self-reported ADEs and preventable ADEs, varying the denominator.

药物安全监测

遗传流行病学统计

ADE = adverse drug event; CI = confidence interval. aAs one person could have multiple ADEs, the combined prevalence is lower than the sum of the prevalences of the ADE categories. bSelf-reported use

NIAID Data Ecosystem40

Supplementary Table 1: Cutaneous adverse events associated with MEK-inhibitors for the treatment of vascular anomalies: a multicenter retrospective study

不良药物反应

MEK抑制剂安全性

Supplementary Table 1: Most common cutaneous adverse events observed in patients with vascular anomalies taking MEK-inhibitors, excluding patients on concurrent therapies.

Mendeley Data10

Prevalence and characteristics of matched treatment episodes by AE.

药物安全监测

临床疗效评估

Prevalence and characteristics of matched treatment episodes by AE.

NIAID Data Ecosystem60

Dechallenge and rechallenge after the onset of hypertension.

不良药物反应

高血压药物安全性

Dechallenge and rechallenge after the onset of hypertension.

NIAID Data Ecosystem10